MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

EPA:ALMLB • FR0013053535

1.79 EUR
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, ALMLB scores 2 out of 10 in our fundamental rating. ALMLB was compared to 30 industry peers in the Household Durables industry. ALMLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALMLB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALMLB had negative earnings in the past year.
  • ALMLB had a negative operating cash flow in the past year.
  • In multiple years ALMLB reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALMLB reported negative operating cash flow in multiple years.
ALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFALMLB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

1.2 Ratios

  • ALMLB's Return On Assets of -1.61% is on the low side compared to the rest of the industry. ALMLB is outperformed by 80.00% of its industry peers.
  • ALMLB has a worse Return On Equity (-3.94%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -1.61%
ROE -3.94%
ROIC N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ALMLB.PA Yearly ROA, ROE, ROICALMLB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • ALMLB has a worse Gross Margin (26.58%) than 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of ALMLB has remained more or less at the same level.
  • ALMLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
ALMLB.PA Yearly Profit, Operating, Gross MarginsALMLB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

  • ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALMLB has about the same amount of shares outstanding.
  • ALMLB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALMLB has an improved debt to assets ratio.
ALMLB.PA Yearly Shares OutstandingALMLB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ALMLB.PA Yearly Total Debt VS Total AssetsALMLB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • ALMLB has an Altman-Z score of 3.49. This indicates that ALMLB is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ALMLB (3.49) is better than 76.67% of its industry peers.
  • ALMLB has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • ALMLB has a Debt to Equity ratio of 0.15. This is in the better half of the industry: ALMLB outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.49
ROIC/WACCN/A
WACC7.23%
ALMLB.PA Yearly LT Debt VS Equity VS FCFALMLB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • ALMLB has a Current Ratio of 1.78. This is a normal value and indicates that ALMLB is financially healthy and should not expect problems in meeting its short term obligations.
  • ALMLB has a Current ratio (1.78) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.85 indicates that ALMLB may have some problems paying its short term obligations.
  • ALMLB has a Quick ratio of 0.85. This is comparable to the rest of the industry: ALMLB outperforms 46.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.85
ALMLB.PA Yearly Current Assets VS Current LiabilitesALMLB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

1

3. Growth

3.1 Past

  • ALMLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.80%.
  • Looking at the last year, ALMLB shows a very negative growth in Revenue. The Revenue has decreased by -10.02% in the last year.
  • ALMLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.42% yearly.
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.16%
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%-7.29%

3.2 Future

  • Based on estimates for the next years, ALMLB will show a very negative growth in Earnings Per Share. The EPS will decrease by -31.83% on average per year.
  • The Revenue is expected to decrease by -8.53% on average over the next years.
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALMLB.PA Yearly Revenue VS EstimatesALMLB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
ALMLB.PA Yearly EPS VS EstimatesALMLB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 -0.2 0.3

4

4. Valuation

4.1 Price/Earnings Ratio

  • ALMLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 5.74, which indicates a rather cheap valuation of ALMLB.
  • Based on the Price/Forward Earnings ratio, ALMLB is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALMLB to the average of the S&P500 Index (28.05), we can say ALMLB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.74
ALMLB.PA Price Earnings VS Forward Price EarningsALMLB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALMLB is valued a bit more expensive than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3038.18
ALMLB.PA Per share dataALMLB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • ALMLB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as ALMLB's earnings are expected to decrease with -31.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.93%
EPS Next 3Y-31.83%

0

5. Dividend

5.1 Amount

  • No dividends for ALMLB!.
Industry RankSector Rank
Dividend Yield 0%

MILIBOO SA

EPA:ALMLB (2/27/2026, 7:00:00 PM)

1.79

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.40M
Revenue(TTM)38.98M
Net Income(TTM)-257.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.74
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.9
P/tB 2.88
EV/EBITDA 3038.18
EPS(TTM)-0.04
EYN/A
EPS(NY)0.31
Fwd EY17.42%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS5.62
BVpS0.94
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.61%
ROE -3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.58%
FCFM N/A
ROA(3y)0.93%
ROA(5y)2.07%
ROE(3y)-1.09%
ROE(5y)23.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.16%
F-Score2
Asset Turnover2.45
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 236.75
Cap/Depr 162.09%
Cap/Sales 2.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.85
Altman-Z 3.49
F-Score2
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)200.54%
Cap/Depr(5y)208.68%
Cap/Sales(3y)2.1%
Cap/Sales(5y)2.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.16%
EPS Next Y17.64%
EPS Next 2Y0.93%
EPS Next 3Y-31.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.02%
Revenue growth 3Y-0.18%
Revenue growth 5Y5.42%
Sales Q2Q%-7.29%
Revenue Next Year-8.57%
Revenue Next 2Y-6.23%
Revenue Next 3Y-8.53%
Revenue Next 5YN/A
EBIT growth 1Y-118.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.04%
EBIT Next 3Y-21.17%
EBIT Next 5YN/A
FCF growth 1Y-215.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.08%
OCF growth 3YN/A
OCF growth 5YN/A

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMLB.PA.


Can you provide the valuation status for MILIBOO SA?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.


How profitable is MILIBOO SA (ALMLB.PA) stock?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.


How financially healthy is MILIBOO SA?

The financial health rating of MILIBOO SA (ALMLB.PA) is 5 / 10.